Zavegepant
Biohaven Pharmaceuticals
[]
dr. rahul ganatra talks to dr. kathleen mullin about the societal impact of migraine and the results of a phase 3 trial of zavegepant nasal spray for migraine relief presented at the american academy of neurology annual meeting. #aanam 
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.